- Meningitis outbreak linked to compounding pharmacy spawns new proposed legislation
- Mass. governor proposes new compounding pharmacy legislation
- Sam's Club leads in customer loyalty rankings
- Report: Walgreens CFO says company is 'better' without Express Scripts
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
WATERTOWN, Mass. — Exergen said a new patent granted to the company protects its temporal artery thermometers brand.
Exergen said its portfolio of intellectual property rights has expanded with the new patent for its TemporalScanner brand of noninvasive thermometry products. Recently, Exergen said it filed a patent infringement suit in the U.S. District Court for the District of Massachusetts against Kidz-Med, American Scientific Resources and Tecnimed SRL.
"This new patent confirms and protects important innovations in noninvasive thermometry contained in our temporal artery thermometers," said Francesco Pompei, Exergen CEO and inventor of the patented technology. "These innovations are central to the overwhelming success of the temporal artery method, which many competitors would like to use. As a U.S. manufacturer, we rely on strong patent protection to protect our rights, and do our part to help protect the spirit of innovation in a highly competitive world."